Market Research Blog

The global wound debridement products market is expected to be valued at US$ 497.3 Billion in 2022. With the rise in incidence of hard and heal wounds, coupled with the increasing number of collaborations and partnerships and new products launches, the overall demand for wound debridement products is projected to grow at a CAGR of 5.6% between 2022 and 2032, totaling around US$ 857.55 Billion by 2032.

Factors such as product innovation, rise in incidence of diabetes cases, increasing healthcare spending and growing aging population globally are the major factors that are anticipated to drive the growth of the wound debridement products. Increasing incidence of hard and heal wounds, growing aging population, rise in prevalence of chronic diseases, increasing adoption of debridement products and techniques and rise in patient population are some other factors that are fueling the market for wound debridement products.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-584

The rising incidence of ulcers is anticipated to further boost the market growth. As per the statistics by the American Diabetes Association, in 2014, about 2.0% of the population was affected with diabetic ulcers in the U.S. Similarly, about 600,000 people are affected by a venous ulcer in the U.S. every year. Therefore, awareness programs for wound care treatment are necessary. In addition, the presence of better healthcare facilities, the adoption of advanced wound care products, developing healthcare infrastructure, and reimbursement policies are driving the market.

Key Takeaways from the Market Study

• From 2017 to 2021, wound debridement products demand expanded at a CAGR of 2.3%
• By product type, the low frequency ultrasound devices constitutes bulk of wound debridement products market worth, with a share of 50%
• By end user, hospitals to account for a major chunk of market revenue, accruing about 55.6% in 2022
• North America to be the kingpin of wound debridement products market, accumulating 32% revenue in 2022
• Europe to trail behind North America, accumulating a revenue share worth 23%
• Asia Pacific to provide credible growth opportunities, expected to yield 20.3% revenue in 2022

“The major factor that boosts the growth of the wound debridement market include increase in incidence of chronic wounds such as pressure ulcers, diabetic foot ulcers, infectious wounds, radiation wounds, arterial ulcers, and acute wound, including burn and trauma,” remarks an FMI analyst.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-584

Competitive Landscape

Players in the global Wound Debridement Products Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

• In January 2021, Healogics launched Healogics 2021. This Healing program is aimed at helping patients and healthcare providers with resources to improve health, heal wounds, and avoid needless amputations.
• In April 2019, RLS Global AB (Sweden) announced that ChloraSolv, its wound care product targeting diabetic foot ulcers, had successfully obtained a CE marking based on confirmation from Lloyd’s Register, acting as Notified Body, and is therefore cleared in 32 European countries for commercialization.
• In July 2017, Smith & Nephew (UK), the global medical technology business, announced to build a new R&D and manufacturing facility for its Advanced Wound Management franchise on the outskirts of Hull, UK.

Know more about what the Wound Debridement Products Market Repost Covers

Future Market Insights offers an unbiased analysis of the global Wound Debridement Products Market, providing historical data for 2017-2021 and forecast statistics from 2022-2032.

To understand opportunities in the Wound Debridement Products Market, the market is segmented on the basis of product type, application, and end-users across five major regions.

Key Segments Covered in the Wound Debridement Products Industry Analysis

Wound Debridement Products Market by Product Type:

• Hydrosurgical Debridement Devices
• Low Frequency Ultrasound Devices
• Surgical Wound Debridement Devices
• Mechanical Debridement Pads
• Traditional Wound Debridement Devices
• Larval Therapy

Wound Debridement Products Market by Application:

• Chronic Ulcers
• Surgical Wounds
• Traumatic Wounds
• Burn Cases

Wound Debridement Products Market by End Users:

• Hospitals
• Ambulatory Surgical Centres
• Specialized Clinics
• Nursing Facilities
• Others

Wound Debridement Products Market by Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-584

Explore FMI’s Extensive ongoing Coverage in Healthcare Domain:

• https://www.patreon.com/posts/humanized-mouse-75411468?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link
• https://drujrake.mn.co/posts/29650467
• https://cigarbook.mn.co/posts/29650496
• https://www.homify.co.uk/ideabooks/9133497/humanized-mouse-model-market-size-share-trends-industry-analysis-research-during-the-ongoing-covid-19-and-research-methodology-by-forecast-to-2032
• https://howtolive.tribe.so/post/humanized-mouse-model-market-size-share-trends-industry-analysis-research-d–638a0ae89d0af802f8d545e1

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR-certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

As per as study by Future Market Insights (FMI), the global market for Halal Nutraceutical and Vaccines is estimated to surpass a valuation of US$ 116.3 Bn by the end of 2031 in comparison to the valuation of US$ 58 Bn in 2021.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-2703

The demand for halal nutraceutical & vaccines is surging particularly in countries with sizeable Muslim demography due to the increasing consumption of halal products. As per the findings by the World and Population Trends, the world’s Muslim population is projected to reach around 2.2 billion people across the globe by the end of 2030.

Growth prospects are likely to remain positive, supported by growing consumer awareness in favor of halal dietary supplements. Considering this, immune and digestive segment is anticipated to register increasing demand in the coming years

Besides this, government initiatives undertaken to produce and promote halal products will present a positive demand outlook. Improving focus on adopting uniform certifications for halal products specifically across India, Singapore and Malaysia will expedite growth of the halal nutraceutical & vaccines market over the assessment period.

Among various applications, the general wellbeing application segment is expected to register impressive growth, accounting for over US$ 41 Mn in 2021. In the coming years, the market will gain from the increasing investments in research and development activities as market players seek to introduce innovations in dietary supplements.

The China market for halal nutraceutical & vaccines is expected to emerge as a highly lucrative pocket in Asia Pacific. Backed by growing demand for halal beauty supplements, the pharmaceutical & nutraceutical companies in China will contribute significantly to the market growth.

“Manufacturers are investing in a slew of new product launches. There is a high emphasis on receiving halal certifications from esteemed organizations. This in turn will continue offering lucrative opportunities of growth for the market in the near future,” said a Future Market Insights analyst.

Key Takeaways from Halal Nutraceutical & Vaccines Market Survey

• Demand outlook for China remains optimistic. Presence of some of the leading players will continue creating opportunities for growth in the country.
• Driven by stringent government regulations regarding halal certification, the UAE market for halal nutraceutical & vaccines will grow at an impressive pace over the forecast period.
• Demand for halal nutraceutical & vaccines will remain considerably high in Japan and South Korea.
• Indonesia market is expected to grow at a steady pace owing to the implementation of favourable government policies.
• Based on distribution channel, Supermarkets are anticipated to account for over 12.71% of market share in 2021.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/ask-question/rep-gb-2703

Key Drivers

• Government initiatives undertaken towards ascertaining supply of healthy food, keeping in mind requirements of diverse demography of consumers will aid growth overall growth of the market.
• Focus on uniform certifications for halal products across Malaysia, Indonesia, UAE, and other regions will create conducive environment for growth of the market.

Competitive Landscape

Halal nutraceutical & vaccines manufacturers are focusing on new product launches to enhance their product portfolio along with addressing changing preferences of consumers.

For instance, in 2020, BlueAngelFarm announced the launch of world’s first Emirates Authority for Standardization and Metrology (ESMA) approved halal multi-vitamin and mineral named Essentials that is primarily manufactured to address unmet vitamin and mineral needs of Muslim women.

For instance, in 2021, Swisse launched the halal-certified Swisse Ultivite E-Senital multivitamins in Singapore. With this new launch, company aims at expanding its portfolio of halal certified products and increasing footprint in the markets with a Muslim majority.

Some of the leading players operating in the halal nutraceutical & vaccines market profiled by Future Market Insights are:

• Chemical Company of Malaysia Berhad
• PT Kalbe Farma TBK
• Noor Vitamins
• AJ Biologics SDN BHD
• Agropur Inc.
• Abbott Laboratories
• Kotra Pharma SDN BHD
• Nestle
• Amway
• Herbalife International of America Inc.
• Others

Customization Available@ https://www.futuremarketinsights.com/customization-available/rep-gb-2703

More Valuable Insights on Halal Nutraceutical & Vaccines Market

FMI, in its new report, offers an unbiased analysis of the global halal nutraceutical & vaccines market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in halal nutraceutical & vaccines market with detailed segmentation:

By Product Type:

• Halal Dietary Supplements
• Halal Vaccines

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Super Markets

By Application:

• Sports Nutrition
• General Wellbeing
• Immune & Digestive Health
• Bone & Joint Health
• Heart Health
• Disease Prevention
• Weight Loss

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

• https://gab.com/Jaydip123/posts/109444550983728718
• https://likefm.org/blog/humanized-mouse-model-market-size-share-trends-industry-analysis-research-during-the-ongoing-covid-19-and-research-methodology-by-forecast-to-2032
• https://www.telecomagent.org/jaydipfmi/humanized_mouse_model_market_size_share_and_research_methodology_by_forecast_to_2032
• https://www.knowasiak.com/humanized-mouse-model-market-size-share-trends-industry-analysis-research-during-the-ongoing-covid-19-and-research-methodology-by-forecast-to-2032/
• https://finbook.com/blogs/2759/Humanized-Mouse-Model-Market-Size-Share-Trends-Industry-Analysis-Research

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The global biopsy devices market is estimated to surpass US$1862.5 million by 2021. In response to the rapidly improving healthcare infrastructure in developing economies and increasing demand for minimally invasive surgeries, the market for biopsy devices is projected to grow at a CAGR of 5.2% during the forecast period 2021 to 2031.

The rising burden of diseases such as lung cancer, breast cancer, leukemia, and others across the globe is accelerating the growth of the market. According to the American Cancer Society, approximately 1.9 million new cases of cancer are likely to be diagnosed in the U.S., out of which 608,570 patients are predicted to succumb in the year 2021.

Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1192

An increasing number of initiatives undertaken by governments and healthcare organizations concerning cancer diagnosis and treatment will facilitate the growth of the market. Driven by the rising healthcare expenditure and progressive research and development (R&D) activities, the market is projected to reach a valuation of US$ 3.08 Bn by the end of 2031.

North America is expected to lead the global biopsy device market. Supported by the rising prevalence of cancer in countries such as the U.S. and Canada, the region is estimated to account for around 34% of the market share in 2021.

“Rising discretionary funding for cancer research, growing government expenditure for upgrading healthcare infrastructure, and implementation of favorable reimbursement policies will collectively propel the growth of the biopsy device market,” says Sabyasachi Ghosh, principal consultant at  Future Market Insights.

Key Takeaways from FMI’s Biopsy Devices Market Survey

• The U.S. is expected to lead the North America market, favored by the presence of favorable reimbursement scenarios in the country.
• Germany is anticipated to hold around 28% of the Europe market share, owing to the growing healthcare expenditure and extensive R&D activities.
• China is projected to account for the highest share in the Asia Pacific biopsy devices market, due to the high patient pool of cancer.

Key Drivers

• Rising prevalence of fatal diseases such as breast cancer and leukemia is fueling demand for biopsy devices.
• Increasing consumer preference towards minimally invasive procedures is spurring sales of biopsy devices.
• Rapid technological advancements such as ultrasound-guided biopsies and 3D optical biopsies is driving the market.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1192

Competitive Landscape

CR Bard, Becton, Dickinson and Company, B. Braun Melsungen AG, Hologic, Inc., Cook Medical, Devicor Medical Products Inc. and Argon Medical Inc.

More Trending Reports by Future Market Research :

• https://www.articlemela.com/3d-printed-medical-implants-market-report-size-growth-and-forecast-2022-2032/
• https://www.exoltech.net/blogs/20703/Humanized-Mouse-Model-Market-Size-Share-Trends-Industry-Analysis-Research
• https://techplanet.today/post/humanized-mouse-model-market-size-share-trends-industry-analysis-research-during-the-ongoing-covid-19-and-research-methodology-by-forecast-to-2032
• https://www.pearltrees.com/jaydipfmi/item486886886
• https://ai.ceo/read-blog/15986_humanized-mouse-model-market-size-share-and-research-methodology-by-forecast-to.html

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9 years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

The global peripheral intravenous catheter market share is expected to observe steady growth during the forecast period. It is anticipated to increase by 9.0% Y-o-Y each year to $18.78 billion in 2032, Wide adoption of catheterization techniques in patient examination, diagnosis, and treatment is anticipated to fuel the demand for PIVC. Rising disease prevalence will play a key role in driving market growth. North America is likely to remain the largest market; Asia Pacific is expected to emerge at the fastest rate.

Soaring disease prevalence will remain a prominent factor driving the demand for catheterization, in turn pushing the market for PIVC. Apart from its usage in drug administration, increasing adoption of peripheral intravenous catheter in body fluid collection during a patient’s physical examination, is also identified to be a key driver to market growth.

Prevalence of infections and epidemics are expected to further spur the demand for catheters in hospitals, clinics, ambulatory surgical centres, home healthcare units, and other healthcare centres. In addition to constantly enhancing healthcare infrastructure, the healthcare spending of consumers is also on the rise, which will favour the market growth.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2558

Technological advancements in PIVC will particularly hold a positive impact on sales, boosting the market. Peripheral intravenous catheter is considered superior to its other counterparts, which will continue to drive adoption as a preferred option over other catheter types, eventually supporting the sales of PIVC.

Moreover, there have been rising efforts toward manufacturing peripheral intravenous catheter using non-irritant, user-friendly material. Moreover, manufacturers are targeting PIVC design improvisation to eliminate the associated complications. This is projected to be a major factor positively influencing the market growth.

A few qualitative and technological complications associated with material composition, design, and after-effects of PIVC are expected to continue affecting mass adoption. In addition, market growth may be restricted due to expensive prices of peripheral intravenous catheter, especially in emerging economies. Conventional PIVC sales can also witness a drop owing to certain stringent medical device regulations in some of the developing countries.

By product, short peripheral intravenous catheter segment will remain dominant over integrated/closed peripheral intravenous catheter segment. Short PIVC segment is further sub-segmented into ported PIVC and non-ported PIVC. While short PIVC segment is expected to register the largest market share of over 71% in 2016, integrated/closed PIVC segment will witness significant Y-o-Y growth of 8.2%. Among the two sub-segments of short PIVC, non-ported PIVC is likely to remain dominant over ported PIVC.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-2558

On the basis of technology, safety peripheral intravenous catheter will continue to gain higher traction than conventional PIVC.

Based on end-user, hospitals segment is likely to generate the maximum PIVC demand. Ambulatory surgical units will also record decent demand. Peripheral intravenous catheter will register maximum revenue sales in 2016 in hospitals, accounting for over 60% market share. Ambulatory surgical units will remain the second most lucrative PIVC end-user segment.

By region, North America is expected to continue the leading position with around 45% share of the entire market revenues in 2016. Europe will continue to be the second largest market for PIVC with a value of over US$ 1.0 Bn in 2016. Asia Pacific is anticipated to emerge as the fastest growing region. Compared to a 5.8% of Y-o-Y of North America, APAC will witness a stronger Y-o-Y growth in 2017 over 2016.

Some of the leading players in peripheral intravenous catheter market, include Becton Dickinson and Company, B. Braun Melsungen AG, Smith Medical, C. R. Bard, Inc., Vygon Group, Terumo Corporation, and Tangent Medical.

Speak to our Research Expert @ https://www.futuremarketinsights.com/ask-question/REP-GB-2558

Market Segmentation

To understand and assess opportunities in the global peripheral intravenous catheter market, we have divided the report into four sections based on market segmentation as under:

By Product Type

• Short PIVC
• Ported PIVC
• Non-ported PIVC
• Integrated/closed PIVC

By Technology

• Conventional PIVC
• Safety PIVC

By End-user

• Hospitals
• Ambulatory surgical centres
• Clinics
• Home use
• Others

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Explore Other Reports Links From Healthcare Market:

• https://club.vexanium.com/post/humanized-mouse-model-market-size-share-trends-industry-analysis-research-d–638a0f990bae9292adc9c968
• https://adhipatialumni.com/blogs/61472/Humanized-Mouse-Model-Market-Size-Share-Trends-Industry-Analysis-Research
• https://waoop.com/read-blog/34030_humanized-mouse-model-market-size-share-trends-industry-analysis-research-during.html
• https://anotepad.com/notes/f65ajn4b
• https://trackthattravel.com/travelblog/27658

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

A new research study by Future Market Insights (FMI) pegs the global cancer supportive care products market to reach USD 32 Bn by 2030. The report titled, ‘Cancer Supportive Care Products Market’ offers in-depth insights on the future market growth, laying out strategies and recommendations that stakeholders can benefit from.

High growth and unmet needs have attracted various new players to cancer supportive care products market. About 23% of compounds in the preclinical drug pipeline were in oncology in 2000, and the number increased to 38% in 2019.

This is increasing the market competition with regards to clinical-trial recruitment – for instance, the number of breast-cancer patients needed for active clinical trials is surpassing the yearly figure of diagnoses.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2550

Efforts to manage drug expenditure have channelized the focus towards cancer supportive care products, especially in developed regions, where value-based health-technology assessments (HTAs) are prevalent.

The cancer supportive care products market is characterized by rapidly growing and globalized standard of medical care. Case in point, in non-small-cell lung cancer, the number of approved therapies was estimated to rise from 14 in 2009 to 22 by 2019.

This, coupled with limited data during accelerated approvals, implies that manufacturers are working in close collaboration with payers to create value proposition of cancer supportive care products.

Key Takeaways of Cancer Supportive Care Products Market Study

• Incidences of cancer have surged by around 26% among geriatric demographics compared to 10% among the remaining population
• Adoption of cancer supportive care products to remain prominent in treating lung cancer
• Pharma companies to invest 30% of their spending in cancer R&D to launch novel drugs and therapies in marketplace
• Market in Asia Pacific (APAC) to experience meteoric growth through 2030

COVID-19 Impact on Cancer Supportive Care Products Market

The COVID 19 pandemic has touched every facet of human life including, healthcare delivery for chronic disorders.

As such, these patients are highly susceptible to getting infected from COVID-19 due to their compromised immunity, putting cancer specialists and patients in a dilemma.

Several healthcare facilities are deferring “elective” screenings, surgeries, and other methods that are considered not urgent or not immediately fatal.

Request for Customization: https://www.futuremarketinsights.com/customization-available/REP-GB-2550

Such important decisions are taken on a case-to-case basis to make sure patients diagnosed with cancer are protected from contracting the coronavirus as well as to ensure that healthcare facilities are equipped with resources necessary to treat cancer patients who do get affected by the virus.

The COVID-19 crisis has disturbed the treatment pathways and in-progress care, thus, resulting in temporary drop in demand for cancer supportive care products.

“In an effort to address the untapped sections of the society, several regulatory bodies are showing immediacy in granting approvals to certain cancer supportive care products. Case in point, the US Food and Drug Administration (FDA) has approved Pfizer’s Nyvepria to help prevent infections in patients undergoing myelosuppressive chemotherapy,” says the analyst at FMI.

Cancer Supportive Care Products Market – Competitive Intelligence

The cancer supportive care products market is highly competitive, with presence of several small- and medium-sized players. Manufacturers are leveraging innovation into their best practices in order to have proper capabilities in place and stay ahead in the fast-growing and competitive arena.

• Baxter International Inc. develops products under the business categories – Renal Care, Medication Delivery, and Pharmaceuticals. The company develops REGLAN Injection, which is a metoclopramide injection.
• Amgen Inc. makes and provides innovative human therapeutics – Neulasta, which is a PEGylated form of human granulocyte CSF.

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/REP-GB-2550  

Want more insights?

Future Market Insights, in its new study, provides compelling insights about the cancer supportive care products market that encloses industry analysis for 2015 – 2019 and opportunity assessment for 2020 – 2030.

The report offers unbiased assessment on cancer supportive care products market through four different categories – by drug class, by indication, distribution channel, and region.

The global cancer supportive care products market research study delivers insights of pricing by different life cycle analysis, product life cycle, major market trends and technologies that are being utilized in the development of cancer supportive care products and product adoption in various end-use sectors.

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

• https://writeablog.net/jaydip-fmi/humanized-mouse-model-market-size-share-trends-industry-analysis-research
• https://www.xing.com/discover/detail-activities/6722353540.67cc5c
• https://forecastanalysis.blogspot.com/2022/12/humanized-mouse-model-market-size-share.html
• https://medium.com/@jaydip.fmi/medical-cleaning-devices-market-recent-trends-demand-dynamic-innovation-in-technology-insights-2f561127d734
• https://pastelink.net/vxxjx4u5

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8 years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

According to a new report published by Future Market Insights titled “Outbound Medical Tourism Services Market: North America Industry Analysis and Opportunity Assessment, 2016-2026”, the North American outbound medical tourism services market size is expected to reach a market valuation of US$ 15.53 Bn by 2016 end and this is likely to increase to US$ 150.36 Bn by 2026.

According to Future Market Insights, factors such as a large aging baby boomer population, a large uninsured population, and better technology, and wider treatment options are expected to drive the revenue growth of the North America outbound medical tourism services market over the forecast period.Economic factors such as rising rate of health insurance premiums, the high cost of medical treatments in the U.S., and parallel tourism with medical treatment are expected to boost the growth of the North America outbound medical tourism services market between 2016 and 2026.

The other factors impacting the North America outbound medical tourism services market are the long waiting time for specialist appointments in the U.S. and the increasing preference for non-conventional treatment options.

The demand for cosmetic correction procedures and dental treatments has been significantly high in the U.S. market in recent years, making North America the most lucrative regional market for outbound medical tourism services.

Request a sample: https://www.futuremarketinsights.com/reports/sample/rep-na-2158

According to the International Society of Aesthetic Plastic Surgery, the U.S. was the largest market for cosmetic procedures in 2015.

Lack of effective follow-up care on returning home, rampant medical malpractices in medical tourism destinations, proliferation of superbugs in medical tourism destinations, problems associated with language barriers, and privacy concerns are some of the challenges anticipated to restrict revenue growth of the North America outbound medical tourism services market over the forecast period.

Segmentation highlights:
The North America outbound medical tourism services market is segmented into the following therapeutic applications – Cosmetic Surgery Treatment, Dental Treatment, Cardiovascular Treatment, Orthopaedic Treatment, Cancer Treatment, Fertility Treatment, Weight Loss Treatment, Spinal Surgery Treatment, Neurology Treatment, and Other General Treatment.

The Cosmetic Surgery Treatment segment is estimated to be valued at US$ 3,760.9 Mn by 2016 end
The Cancer Treatment segment is anticipated to register a CAGR of 22.0% over the forecast period
The Orthopaedic Treatment segment is estimated to create absolute $ opportunity of US$ 1,658.9 Mn in 2017 over 2016
Regional forecast:
The North America outbound medical tourism services market is segmented into the two top countries of U.S and Canada. U.S. is projected to occupy a major share in the North America outbound medical tourism services market in terms of value.
Get In Touch With Our Team For 20% Flat Discount: https://www.futuremarketinsights.com/ask-question/rep-na-2158

The U.S market is anticipated to be valued at US$ 14.98 Bn by the end of 2016. In terms of value, U.S. is expected to be the dominant regional market by 2026 end and is expected to register a CAGR of 25.7% over the forecast period.

Canada is expected to have comparatively less market potential for outbound medical tourism services, registering a CAGR of 18.1% over the forecast period.

Vendor insights:

The report profiles some of the top companies operating in the North America outbound medical tourism services market.

Leading market players featured in the report are Apollo Hospital Enterprise Limited, Bumrungrad International Hospital, KPJ Healthcare Berhad, Christus Muguerza Hospital, WorldMed Assist, Mednamaste, and Global Medical Tourism Inc.

Major market players are adopting strategies such as market expansion and strategic alliances to maintain their market share.

Some of these companies are also adopting strategies such as backward integration to support their core business of medical tourism.

Companies are offering services such as insurance and financing for medical tourism and are looking to expand their global footprint by enhancing their foreign customer base.

Market segmentation:

By Therapeutic Application
Cosmetic Surgery Treatment
Dental Treatment
Cardiovascular Treatment
Orthopaedic Treatment
Cancer Treatment
Fertility Treatment
Weight Loss Treatment
Spinal Surgery Treatment
Neurology Treatment
Other General Treatment

By Region
U.S
Canada

Request for Customization: https://www.futuremarketinsights.com/customization-available/rep-na-2158

Explore Other Reports Links From Healthcare Market:

• https://homment.com/spZPh94QlUzU1LlEc4iB
• https://theprose.com/post/546623/medical-cleaning-devices-market-recent-trends-demand-dynamic-innovation-in-technology-insights-2032
• https://acatpg.mn.co/posts/29652967
• https://faceblox.mn.co/posts/29652978
• https://globalsocials.mn.co/posts/29652983

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR-certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 4 years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

 The global portable oxygen concentrators market is anticipated to witness lucrative growth opportunities over the forecast period from 2022 and 2032, with a phenomenal CAGR of 10.1%. The market is expected to enjoy a valuation of US$ 1.9 Bn by the end of the year 2022 and surpass a projection of US$ 5.0 Bn by the year 2032. According to the Future Market Insights historical analysis, the pulse flows portable oxygen concentrators were leading the market with a share of about 67.7% in the year 2021, within the global market. In the year 2021, the market value for portable oxygen concentrators was around 54.8% of the overall US$ 3.5 Bn of the global oxygen concentrators market.

Portable oxygen concentrators supply oxygen to those patients who are suffering from respiratory diseases such as chronic obstructive pulmonary disease. In this process, nitrogen and oxygen are separated from the air in the environment with the help of the concentrator which then discards the nitrogen and supplies 95% pure oxygen to patients through a mask. As compared to homecare oxygen concentrators, portable oxygen concentrators allow patients to easily carry the devices. Apart from patients, POCs are also used by mountaineers and travelers in places where oxygen is inadequate. The crucial factors leading to the surge of portable oxygen concentrators over the projection period comprise an upgraded lifestyle and an increase in the rate of smoking

To Get a Sample Copy of the Report visit: https://www.futuremarketinsights.com/reports/sample/rep-gb-1061

There is a significant surge in the geriatric population, which is rising the requirement for home care settings, especially in developed countries. The increasing number of patients with chronic obstructive pulmonary disease (COPD) and respiratory diseases is expected to drive demand for portable oxygen concentrators during the projected period.

Key Takeaways

• The surge in the adoption of portable oxygen concentrators is significant in developing nations, owing to the due to increasing incomes and technological advancements that will create positive opportunities for the portable oxygen concentrators market. Globally there is an overall surge in COPD patients, especially in countries like India and China. Therefore, this factor will increase the demand for portable oxygen concentrators globally.
• In addition to that, with the surge in the investment by several companies for the production of continuous flow of oxygen, the portable oxygen concentrators market is expected to fuel up. Major players in the market are focusing on enhancing the durability of oxygen concentrators and also increasing production efficiency which will address the demand for portable oxygen concentrators. The above-mentioned factors are expected to propel growth in the global portable oxygen concentrators market.
• An unhealthy lifestyle is on the rise, and the young population is increasingly consuming marijuana, cigars, and pipes which is fueling the growth of the portable oxygen concentrators market globally. In addition to that, the shift from regular conventional concentrators to portable oxygen concentrators is encouraging market growth for portable oxygen concentrators.
• Moreover, the use of advanced technologies in the production of oxygen concentrators by manufacturers is also driving the growth of the market. Key market players are focusing on designing products with efficacy and affordability in order to address increasing the demand for portable oxygen concentrators.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1061

Competitive Landscape

In the portable oxygen concentrators market, dominant manufacturers are widely adopting different activities which will help them raise sales and gain revenue. In order to meet the demand of consumers and expand these firms, several activities are being implemented including advanced products launched among others.

Key Players:

• Koninklijke Philips N.V.
• Inogen, Inc
• Chart Industries, Inc.
• Resmed, Inc.
• Invacare Corporation
• Drive DeVilbiss Healthcare LLC
• Precision Medical, Inc.
• Besco Medical Co. Ltd.
• Oxus America, Inc.
• Foshan KeyhubElectronic Industries Co. Ltd.
• O2 Concepts LLC
• GCE Group

More Insights into the Portable Oxygen Concentrators Market

The U.S. is expected to dominate the global portable oxygen concentrators market as it accounted for around 86.6% of the total market share in 2021. The North American region is expected to maintain its dominance over the assessment period. Due to the growth in the incidence of COPD and the rising number of patients in the United States, the market for portable oxygen concentrators maintains a sizable market share.

In 2021, India accounted for a market share of around 2.7% in the global portable oxygen concentrators market across the forecast period. In 2020, the Covid-19 pandemic surged the sales of portable oxygen concentrators market in India to a massive scale.

Buy This Report: https://www.futuremarketinsights.com/checkout/1061

Key Market Segments Covered in Portable Oxygen Concentrators Industry Research

By Product:

• Continuous Flow Portable Oxygen Concentrator
• Pulse Flow Portable Oxygen Concentrator

By End User:

• Hospitals
• Homecare
• Ambulatory Surgical Centres
• Travel Agents

Explore FMI’s Extensive ongoing Coverage in Healthcare Domain:

• https://primal-dread.mn.co/posts/medical-cleaning-devices-market-recent-trends-demand-dynamic-innovation-in-technology-insights-2032
• https://www.patreon.com/posts/medical-cleaning-75414599?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link
• https://drujrake.mn.co/posts/29653156
• https://cigarbook.mn.co/posts/29653174
• https://www.homify.co.uk/ideabooks/9133556/medical-cleaning-devices-market-recent-trends-demand-dynamic-innovation-in-technology-insights-2032

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs